CXXC1 and neoplasm: To explore whether high CFP1 expression was associated with patients’ clinical outcomes, we conducted survival analyses using GSE31210, GSE41271, and GSE30219 datasets, and the results showed that patients with high CFP1 expression of tumor tissues had shorter overall survival (OS) and disease-free survival (DFS) than patients with low CFP1 expression (Fig. 1d–g, Supplementary Fig. 1c, d).